If we're talking about taking it at the expense of someone else getting it, no. I'm not in any high risk group, and so other people would benefit more.
I also know people in pharma, and I know how they do statistics for this type of thing. There could be rare side-effects that, by choice of study size and luck, have not come to light (with 43k participants, they'd only see side effect that affects 1 in 100k people about 1/3 of the time). And they've only had less than a year, so there's no way to observe if there are long-term side effects. Again, though, I'm in a low risk group. Those odds might be acceptable for someone in a higher risk group.
If we're talking about taking it at the expense of someone else getting it, no. I'm not in any high risk group, and so other people would benefit more.
I also know people in pharma, and I know how they do statistics for this type of thing. There could be rare side-effects that, by choice of study size and luck, have not come to light (with 43k participants, they'd only see side effect that affects 1 in 100k people about 1/3 of the time). And they've only had less than a year, so there's no way to observe if there are long-term side effects. Again, though, I'm in a low risk group. Those odds might be acceptable for someone in a higher risk group.